Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE

SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2024

 

Commission File Number: 001-40413

 

 

 

Quipt Home Medical Corp.

(Translation of registrant’s name into English)

 

 

 

1019 Town Drive

Wilder, Kentucky 41076

(Address of principal executive office)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ¨                Form 40-F x

 

 

 

 

 

 

EXHIBIT INDEX

Exhibit		Description
99.1		Press Release dated May 6, 2024

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	Quipt Home Medical Corp.
Date: May 6, 2024	/s/ Gregory Crawford
	Chief Executive Officer

 

 

 

 

Exhibit 99.1

 

Quipt Home Medical CORP. to announce FISCAL SECOND Quarter 2024 Financial Results on MAY 15, 2024

 

Cincinnati, Ohio – May 6, 2024 – Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal second quarter 2024 financial results on Wednesday, May 15, 2024. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Thursday, May 16, 2024, at 10:00 a.m. (ET).

 

The call-in numbers for participants are:

 

	Canada/US Toll Free:	1 [phone]
	International:	1 [phone]

 

A live webcast of the call will be accessible via the investor section of the Company’s website through the following link: www.quipthomemedical.com.

 

ABOUT QUIPT HOME MEDICAL

 

The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services, and making life easier for the patient.

 

For further information please visit our website at www.quipthomemedical.com, or contact:

 

Cole Stevens

VP of Corporate Development

Quipt Home Medical Corp.

859-300-6455

[e-mail]

 

Gregory Crawford

Chief Executive Officer

Quipt Home Medical Corp.

859-300-6455

[e-mail]

 

 

 

---